SOURCE: BioDefense Corporation

October 26, 2009 08:58 ET

BioDefense Corporation and Biotest Laboratories, Inc. Combine to Launch MAIL SAFE CHECK™ New, Easy-to-Use, Diagnostic Tool to Protect Employees From Incoming Mail Containing Deadly Pathogens or Other Weapons of Mass Destruction

NEW YORK, NY--(Marketwire - October 26, 2009) - International Security Conference -- Boston-based BioDefense Corporation and producer of MailDefender (www.biod.com) and Biotest Laboratories, Inc, of Minneapolis, MN (www.biotestlabs.com), have joined forces to create a new, unique incoming mail diagnostic tool called MAIL SAFE CHECK™.

BioDefense Corporation produces MailDefender, the world's ONLY device that KILLS anthrax and other dangerous substances concealed in mail in the office environment. Biotest Laboratories, Inc. (www.biotestlabs.com) of Minneapolis is employing its unique Microbial Management (Evariology) System to ensure that dangerous pathogens found in incoming mail -- i.e. anthrax, smallpox, ricin, etc. -- are neutralized.

The immediate result of the convergence of these technologies is MAIL SAFE CHECK, a new, fast, inexpensive method to determine if incoming mail could be affected with dangerous pathogens.

NEW MAIL SAFE CHECK AT-A-GLANCE

Mailroom, security, and executives at all levels concerned with protection of employees from harmful substances simply sign up for MAIL SAFE CHECK, quickly receiving the anti-bioterrorism Sterilization Challenger Test Pack. The easy-to-use tool tests the mail security process, and the user sends the test pack to Biotest Laboratories, Inc. for confirmation. Within a few days, the user will receive a report identifying a security vulnerability, susceptible to pathogens, from H1N1, which "lives" on everyday paper, to truly frightening substances such as smallpox, ricin, and more.

MAIL SAFE CHECK is available at $999, including shipping and handling, at www.mailsafecheck.com or a company's preferred security vendor. All major credit and debit cards accepted.

According to John Meyer, BioDefense Corporation president, "Anthrax attacks -- either as a hoax, or the very deadly real thing -- are a continual headache to the security community, because this dangerous pathogen is easily sent through the mail. MailDefender is the ONLY equipment that actually kills dangerous bio-pathogens and is now rated capable of killing weaponized anthrax, one of the deadliest organisms available in the bio-terrorism arsenal. H1N1, smallpox, SARS, avian flu, and many other dangerous substances can now be killed in a user's office location."

Biotest Laboratories and President Gregg Mosley, a world-renowned expert in sterilization of medical products, said, " We have created a system for "Managing Microbes" based on principles of Evariology that allows trending and tracking of problematic organisms for medical manufacturers. It is a risk management process involving proactive bioburden monitoring devices and production environment, allowing identification and prevention of the root causes of contamination.

"Application of these same principles is the core of MAIL SAFE CHECK to identify various attack organisms or toxins and potentially predict what biological weapon may be used by terrorists and where such an attack could occur," explained Mr. Mosley.

About Biotest Laboratories, Inc.

Biotest Laboratories, Inc. was organized by Gregg A. Mosley in 1988 as a test laboratory for manufacturers of medical products. To meet growing customer requests, Biotest Laboratories has developed areas of Contract Manufacturing, Packaging/Assembly, Contract Steam Sterilization, Cleanroom/Cleanbench Testing and Certification, Validation Services, Microbial Management (Evariology), and Training and Consulting Services. The company has 80 employees and is headquartered at 8990 Springbrook Drive NW, Suite 100, Minneapolis, MN 55433. Telephone 763-785-2414 or visit www.biotestlabs.com.

About BioDefense Corporation

Over the past eight years, BioDefense Corporation has developed multiple Mail Defender prototypes, and is now bringing to market its first commercial production unit. BioDefense has secured a patent for the technology containing over 30 claims, and has completed independent testing from multiple laboratories under government supervision confirming the efficacy of the technology. Current customers for the Mail Defender include the United Nations, U.S. Military, and other high-profile government and financial institutions. Headquarters are at 12 Channel Street, Boston, MA 02210. Tel: 617-778-1800.

Contact Information

  • For further information contact:

    Joy Mosley
    Biotest Laboratories, Inc.
    763-785-2414
    Email Contact

    Steven Swartz
    SIZZLE PR
    978-5524-9595
    Email Contact